140 related articles for article (PubMed ID: 36142900)
1. Surgical Outcomes, Long-Term Survivals and Staging Systems of World Health Organization G3 Pancreatic Neuroendocrine Tumors.
Yang M; Zeng L; Hou S; Tian B; Jin S; Zhang Y
J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142900
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract][Full Text] [Related]
3. Survivals of patients with pancreatic neuroendocrine carcinomas: An in-depth analysis by the American Joint Committee on Cancer 8th tumor-node-metastasis staging manual.
Deng BY; Yang M; Wen JY; Hou SZ; Chen Y; Tian BL; Liu XB; Zhang Y
Medicine (Baltimore); 2020 Jan; 99(3):e18736. PubMed ID: 32011453
[TBL] [Abstract][Full Text] [Related]
4. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
[TBL] [Abstract][Full Text] [Related]
5. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution.
Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649
[TBL] [Abstract][Full Text] [Related]
6. Survivals of patients with surgically treated and High-grade pancreatic neuroendocrine carcinomas: A comparative study between two American Joint Committee on Cancer 8th tumor-node-metastasis staging systems.
Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
Eur J Surg Oncol; 2019 Jun; 45(6):1054-1060. PubMed ID: 30661921
[TBL] [Abstract][Full Text] [Related]
7. Applications of a novel tumor-grading-metastasis staging system for pancreatic neuroendocrine tumors: An analysis of surgical patients from a Chinese institution.
Yang M; Tan CL; Zhang Y; Ke NW; Zeng L; Li A; Zhang H; Xiong JJ; Guo ZH; Tian BL; Liu XB
Medicine (Baltimore); 2016 Jul; 95(28):e4213. PubMed ID: 27428224
[TBL] [Abstract][Full Text] [Related]
8. TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.
Yang M; Zeng L; Zhang Y; Wang WG; Wang L; Ke NW; Liu XB; Tian BL
Medicine (Baltimore); 2015 Mar; 94(12):e660. PubMed ID: 25816036
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
[TBL] [Abstract][Full Text] [Related]
10. Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?
Yang M; Ke NW; Zhang Y; Tan CL; Tian BL; Liu XB; Huang W; Nunes Q; Sutton R
Oncotarget; 2017 Oct; 8(47):82784-82795. PubMed ID: 29137302
[TBL] [Abstract][Full Text] [Related]
11. Surgical Outcomes and Prognostic Factors of G3 Pancreatic Neuroendocrine Carcinomas: A Consecutive Analysis Based on Previous Study Results.
Luo X; Yang M; Tian B; Liu X; Duan K; Zhang Y
J Clin Med; 2022 Jun; 11(11):. PubMed ID: 35683561
[TBL] [Abstract][Full Text] [Related]
12. Development and Validation of a Modified Eighth AJCC Staging System for Primary Pancreatic Neuroendocrine Tumors.
Zhang XF; Xue F; Wu Z; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lyu Y; Maithel SK; Pawlik TM
Ann Surg; 2022 Jun; 275(6):e773-e780. PubMed ID: 32511134
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors.
Kim BS; Park YS; Yook JH; Kim BS
Medicine (Baltimore); 2016 Jul; 95(30):e3977. PubMed ID: 27472674
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
16. Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study.
Rindi G; Klersy C; Albarello L; Baudin E; Bianchi A; Buchler MW; Caplin M; Couvelard A; Cros J; de Herder WW; Delle Fave G; Doglioni C; Federspiel B; Fischer L; Fusai G; Gavazzi F; Hansen CP; Inzani F; Jann H; Komminoth P; Knigge UP; Landoni L; La Rosa S; Lawlor RT; Luong TV; Marinoni I; Panzuto F; Pape UF; Partelli S; Perren A; Rinzivillo M; Rubini C; Ruszniewski P; Scarpa A; Schmitt A; Schinzari G; Scoazec JY; Sessa F; Solcia E; Spaggiari P; Toumpanakis C; Vanoli A; Wiedenmann B; Zamboni G; Zandee WT; Zerbi A; Falconi M
Neuroendocrinology; 2018; 107(4):375-386. PubMed ID: 30300897
[TBL] [Abstract][Full Text] [Related]
17. Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems.
Lu J; Zhao YJ; Zhou Y; He Q; Tian Y; Hao H; Qiu X; Jiang L; Zhao G; Huang CM;
Br J Surg; 2020 Feb; 107(3):248-257. PubMed ID: 31971627
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
[TBL] [Abstract][Full Text] [Related]
19. Critical updates in neuroendocrine tumors: Version 9 American Joint Committee on Cancer staging system for gastroenteropancreatic neuroendocrine tumors.
Chauhan A; Chan K; Halfdanarson TR; Bellizzi AM; Rindi G; O'Toole D; Ge PS; Jain D; Dasari A; Anaya DA; Bergsland E; Mittra E; Wei AC; Hope TA; Kendi AT; Thomas SM; Flem S; Brierley J; Asare EA; Washington K; Shi C
CA Cancer J Clin; 2024 Apr; ():. PubMed ID: 38685134
[TBL] [Abstract][Full Text] [Related]
20. Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms.
Shi H; Chen L; Zhang Q; Lin Y; Jiang C; Yao H; Hou X; Chen M; Lin R; Chen J
Pancreas; 2020; 49(10):1378-1382. PubMed ID: 33122528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]